SATELLOS BIOSCIENCE INC.(MSLE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MSLE SATELLOS BIOSCIENCE INC.

未开盘 04-27 16:00:00 EDT

7.16

+0.18

+2.58%

盘后7.16

+0.000.00%

17:09 EDT

最高7.35	最低6.86	成交量4.21万
今开6.93	昨收6.98	日振幅7.09%
总市值1.48亿	流通市值1.25亿	总股本2,063万
成交额29.95万	换手率0.24%	流通股本1,751万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MSLE","market":"US","secType":"STK","nameCN":"SATELLOS BIOSCIENCE INC.","latestPrice":7.16,"timestamp":1777320000000,"preClose":6.98,"halted":0,"volume":42149,"hourTrading":{"tag":"盘后","latestPrice":7.16,"preClose":7.16,"latestTime":"17:09 EDT","volume":702,"amount":5070.4753,"timestamp":1777324140626,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.025787965616045804,"floatShares":17510300,"shares":20626900,"eps":-1.704123,"marketStatus":"未开盘","change":0.18,"latestTime":"04-27 16:00:00 EDT","open":6.93,"high":7.3499,"low":6.855,"amount":299464.2446444,"amplitude":0.070903,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.704123,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777363200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":6.98,"postHourTrading":{"tag":"盘后","latestPrice":7.16,"preClose":7.16,"latestTime":"17:09 EDT","volume":702,"amount":5070.4753,"timestamp":1777324140626,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.382732},"requestUrl":"/m/hq/s/MSLE","defaultTab":"news","newsList":[{"id":"1185604934","title":"Leerink Partners首次覆盖Satellos Bioscience，给予\"跑赢大盘\"评级，目标价20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185604934","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185604934?lang=zh_cn&edition=full","pubTime":"2026-04-06 18:10","pubTimestamp":1775470214,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners近日发布研究报告，首次将生物科技公司Satellos Bioscience Inc.（股票代码：MSLE）纳入覆盖范围。\n该机构给予该公司\"跑赢大盘\"的积极评级，并设定了20美元的目标股价。这一评级反映了分析师对Satellos Bioscience未来发展前景的乐观预期。\n作为一家专注于创新疗法研发的生物技术企业，Satellos Bioscience凭借其独特的技术平台吸引了市场关注。Leerink Partners此次覆盖，将为投资者提供专业的研究参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSLE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186185180","title":"Oppenheimer调整Satellos Bioscience目标价至$40 反映1:12合股影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1186185180","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186185180?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:40","pubTimestamp":1770730816,"startTime":"0","endTime":"0","summary":"投资机构Oppenheimer宣布更新对生物科技公司Satellos Bioscience Inc.的目标股价评估。此次调整将目标价从原先的5美元大幅上调至40美元，主要原因是该公司近期实施了1股合并为12股的反向股票分割操作。\n这一价格变动纯粹反映合股后的股本结构变化，并不代表投资机构对该公司基本面或估值观点的实质性改变。反向拆股通常被上市公司用于提升每股交易价格，以满足交易所的上市维持标准或改善市场流动性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSLE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.satellos.com;ir.satellos.com","stockEarnings":[{"period":"1week","weight":-0.0856},{"period":"1month","weight":0.1567},{"period":"3month","weight":-0.4272},{"period":"ytd","weight":-0.4272}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Satellos Bioscience Inc.于2006年4月20日根据《商业公司法》（不列颠哥伦比亚省）注册成立。该公司是一家临床阶段的药物开发公司，致力于开发退行性肌肉疾病的治疗方法。其主要候选药物SAT-3247是一种口服小分子，旨在恢复杜氏肌营养不良症等情况下的骨骼肌再生。该候选药物目前正在两项名为BASECAMP和TRAILHEAD的试验中进行临床评估。该公司继续利用其专有的MyoReGenX平台来确定退行性肌肉疾病的额外治疗机会。","exchange":"NASDAQ","name":"SATELLOS BIOSCIENCE INC.","nameEN":"SATELLOS BIOSCIENCE INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SATELLOS BIOSCIENCE INC.(MSLE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SATELLOS BIOSCIENCE INC.(MSLE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SATELLOS BIOSCIENCE INC.,MSLE,SATELLOS BIOSCIENCE INC.股票,SATELLOS BIOSCIENCE INC.股票老虎,SATELLOS BIOSCIENCE INC.股票老虎国际,SATELLOS BIOSCIENCE INC.行情,SATELLOS BIOSCIENCE INC.股票行情,SATELLOS BIOSCIENCE INC.股价,SATELLOS BIOSCIENCE INC.股市,SATELLOS BIOSCIENCE INC.股票价格,SATELLOS BIOSCIENCE INC.股票交易,SATELLOS BIOSCIENCE INC.股票购买,SATELLOS BIOSCIENCE INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SATELLOS BIOSCIENCE INC.(MSLE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SATELLOS BIOSCIENCE INC.(MSLE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}